Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

RecruitingOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Pancreatic Ductal Adenocarcinoma
Trial Locations (4)

Unknown

ACTIVE_NOT_RECRUITING

EUROPAC study, University of Liverpool, Liverpool

ACTIVE_NOT_RECRUITING

ADEPTS study, University College London, London

ACTIVE_NOT_RECRUITING

Imperial College London, London

RECRUITING

Royal London Hospital, London

All Listed Sponsors
collaborator

University of Liverpool

OTHER

collaborator

University College, London

OTHER

collaborator

Imperial College London

OTHER

collaborator

Pancreatic Cancer Research Fund

UNKNOWN

collaborator

Ospedale San Raffaele

OTHER

lead

Queen Mary University of London

OTHER